We are live on
!
Find out more
MP
Mangrove Partners Portfolio holdings
AUM
$1.24B
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$584M
AUM Growth
+$93.1M
(+19%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
12.53%
Top 10 Holdings %
Top 10 Hldgs %
75.46%
Holding
33
New
9
Increased
14
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQC
Equity Commonwealth
EQC
|
+$28.6M |
| 2 |
CIVI
Civitas Resources
CIVI
|
+$12.8M |
| 3 |
PennyMac Financial
PFSI
|
+$12.4M |
| 4 |
EGLE
Eagle Bulk Shipping Inc.
EGLE
|
+$10.1M |
| 5 |
Peabody Energy
BTU
|
+$7.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$20.7M |
| 2 |
SunCoke Energy
SXC
|
+$3.77M |
| 3 |
Warrior Met Coal
HCC
|
+$1.92M |
| 4 |
TGH
Textainer Group Holdings limited
TGH
|
+$1.52M |
| 5 |
International Seaways
INSW
|
+$51.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 26.11% |
| 2 | Communication Services | 14.5% |
| 3 | Materials | 12.32% |
| 4 | Real Estate | 11.63% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRRX
26
DELISTED
DURECT Corp
DRRX
| $2.25M | 0.39% |
127,159
+93,207
| +275% | +$1.56M |
|
27
Larimar Therapeutics
LRMR
$416M
| $1.97M | 0.34% |
+46,665
| New | +$1.94M |
|
|
BPT
28
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $1.57M | 0.27% |
+69,872
| New | +$1.42M |
|
|
ADVM
29
DELISTED
Adverum Biotechnologies
ADVM
| $1.51M | 0.26% |
+41,384
| New | +$1.15M |
|
30
uniQure
QURE
$2.68B
| $1.02M | 0.18% |
106,634
+66,763
| +167% | +$537K |
|
|
31
Elevance Health
ELV
$81.9B
| – | – |
-110,000
| Closed | -$20.7M |
|
|
TGH
32
DELISTED
Textainer Group Holdings limited
TGH
| – | – |
-104,756
| Closed | -$1.52M |
|
Similar funds
GX
HCA
CA
WTA
NHAS
FLII
CCA
IC
Mangrove Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Mangrove Partners held 33 positions worth $584M, up 19% from $490M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Mangrove Partners deployed $73.1M of net new capital in Q3 2017, opening 9 new positions and adding to 14 existing holdings. Its largest new stake was PennyMac Financial: 716,835 shares worth $12.8M.
By sector, the portfolio is most concentrated in Energy at 26% of assets, up from 25% a quarter earlier, followed by Communication Services and Materials.
On the sell side, the largest reduction was SunCoke Energy, an estimated $3.77M trimmed.
- Mangrove Partners's largest Q3 2017 buy was PennyMac Financial: 716,835 shares worth $12.8M.
- Mangrove Partners added most to Equity Commonwealth in Q3 2017, an estimated $28.6M increase.
- Mangrove Partners's biggest Q3 2017 reduction was SunCoke Energy, cutting an estimated $3.77M.
- Mangrove Partners fully exited Elevance Health in Q3 2017, selling an estimated $20.7M.
- Mangrove Partners's ten largest holdings make up 75% of its $584M portfolio in Q3 2017.
- Mangrove Partners opened 9 new positions and closed 2 in Q3 2017.
- Mangrove Partners's portfolio value rose 19% quarter-over-quarter to $584M.
Based on Mangrove Partners's 13F filing for Q3 2017, filed 14 Nov 2017.